Table 1.
Demographic and Clinical Characteristics of 30 Subjects Without Diabetes (Control) and 30 Subjects With Diabetes
| Characteristic | Control Group | Diabetes Group | P |
|---|---|---|---|
| Age, y | 59.2 ± 7.1 | 61.2 ± 5.1 | .23 |
| Race/ethnicity | |||
| White | 40 | 33 | |
| Hispanic | 23 | 20 | .73 |
| African American | 37 | 47 | |
| Height, cm | 177.2 ± 6.3 | 175.2 ± 5.9 | .44 |
| Weight, kg | 86.0 ± 16.8 | 92.9 ± 16.8 | .12 |
| BMI | 27.6 ± 4.8 | 30.3 ± 4.9 | .04 |
| Most recent serum glucose level, mg/dL | 95 ± 12 | 163 ± 98 | <.01 |
| Hemoglobin A1c level, % | 5.5 ± 0.3 | 7.9 ± 1.6 | <.01 |
| Active smoking | 17 | 23 | .75 |
| Antibiotic use in prior 12 mo | 30 | 30 | 1.00 |
| Known skin condition | 23 | 23 | 1.00 |
| History of malignancy | 20 | 13 | .73 |
| Vascular disease | 10 | 23 | .3 |
| Statin use | 30 | 77 | <.01 |
| NSAID use | 30 | 57 | .12 |
| Time since last shower, h | 12.2 ± 10.8 | 8.4 ± 10.2 | .17 |
| High temperature on sampling day, °C | 15.8 ± 5.2 | 18.2 ± 7.6 | .16 |
Data are no. of subjects or mean ± SD.
Abbreviations: BMI, body mass index (defined as the weight in kilograms divided by the height in square meters); NSAID, nonsteroidal antiinflammatory drug.